User menu

Cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients age 60 years or older with previously untreated acute myeloid leukemia.

Bibliographic reference Giles, Francis ; Rizzieri, David ; Karp, Judith ; Vey, Norbert ; Ravandi, Farhad ; et. al. Cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients age 60 years or older with previously untreated acute myeloid leukemia.. In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 25, no. 1, p. 25-31 (2007)
Permanent URL http://hdl.handle.net/2078.1/26942